Table 3. The cost-effectiveness results of CIC-PDD

From: Cost-effectiveness of community-based integrated care model for patients with diabetes and depressive symptoms

Cost Perspective

Cost difference- US dollar (95% CI)

Effectiveness difference-QALYs (95% CI)

ICER-US dollar

Probability of cost-effectiveness, %

Effectiveness difference-DFDs (95% CI)

ICER- US dollar

WTP per DFD to achieve probability of cost-effectiveness > 95%

Unadjusted analysis

 Health System

199.58 (−318.99 to 718.15)

0.03 (0.01 to 0.04)

7922.82

66.41 to 94.45

70.89 (61.76 to 80.02)

2.82

9.00

 Multipayer

197.08 (−339.76 to 733.93)

7823.85

66.28 to 94.30

2.78

9.50

 Societal

186.65 (−452.70 to 825.99)

7409.46

65.31 to 93.37

2.63

10.50

Adjusted analysisa

 Health System

262.74 (−300.95 to 826.42)

0.03 (0.00 to 0.05)

10207.39

66.20 to 91.35

75.59 (61.98 to 89.20)

3.48

8.00

 Multipayer

266.20 (−326.73 to 859.13)

10341.94

66.13 to 91.25

3.52

9.00

 Societal

295.44 (−438.15 to 1029.02)

11477.82

65.22 to 90.50

3.91

9.50

  1. DFDs depression-free days, QALYs quality-adjusted life years, ICER incremental cost-effectiveness ratio, WTP willingness-to-pay.
  2. aAdjusted analyses were conducted using a two-sided Generalized Linear Model (GLM) with a Gamma distribution, incorporating baseline outcome adjustments.
Back to article page